This content is machine translated Clinical relevance, benefits and limitations Atrial Fibrillation Screening Screening for atrial fibrillation is considered a potentially effective strategy for preventing strokes at an early stage. But how great is the actual benefit in clinical care? A recent meta-analysis...…
View Post 7 min This content is machine translated Atrial fibrillation: interdisciplinary effort is crucial Managing risk factors and comorbidities in addition to rhythm control The previously used “ABC” scheme was replaced by the more comprehensive “CARE” approach in the ESC guideline published in 2024. Drug therapy for atrial fibrillation is primarily aimed at preventing...…
View Post 8 min This content is machine translated HFpEF 2025 Precision medicine and phenotypes In 2025, heart failure with preserved ejection fraction (HFpEF) is less than ever a single clinical picture – it is an umbrella over many phenotypes with different triggers, pathomechanisms and...…
View Post 9 min This content is machine translated Catheter ablation for atrial fibrillation 2025 Pulsed field versus radio frequency – where do we stand? In the treatment of atrial fibrillation (AF), catheter ablation has developed from a specialized option to the mainstay of a modern rhythm strategy within a decade. In 2025, two developments...…
View Post 6 min This content is machine translated DOAK optimization, ABC pathway and lessons learned from the FXI/XIa pipeline Stroke prevention for atrial fibrillation 2025 Atrial fibrillation is the most important treatable risk factor for ischemic strokes in 2025 – and at the same time an area where precision makes all the difference. The major...…
View Post 4 min This content is machine translated Study report Digital patient education for atrial fibrillation shows measurable effects The prevalence of atrial fibrillation is increasing and efforts are underway to implement innovative care concepts. In this context, a digitalized patient training course was evaluated as part of a...…
View Post 4 min This content is machine translated Atrial fibrillation What’s new with the “pace-and-ablate” strategy? Atrial fibrillation (AF) is the most common cardiac arrhythmia and is associated with increased morbidity and mortality. The guideline of the European Society for Cardiology (ESC), which was updated last...…
View Post 7 min This content is machine translated Anticoagulation for atrial fibrillation New ESC guideline has adapted recommendations Atrial fibrillation is the most common persistent cardiac arrhythmia in adults. In the new guidelines for the management of atrial fibrillation, the European Society of Cardiology (ESC) pays particular attention…
View Post 6 min This content is machine translated Anticoagulation for atrial fibrillation (AFib) HAS-BLED score as a reference point for risk stratification Atrial fibrillation (AFib) is a common cardiac arrhythmia and increases the risk of suffering a stroke. According to the current ESC guideline, patients with VHF without a clear contraindication should…
View Post 9 min This content is machine translated Screening for atrial fibrillation is not a sure-fire success Oral anticoagulation in AHRE risky and ineffective Anticoagulants increase the risk of bleeding but do not prevent strokes in patients with atrial high rate episodes (AHRE) and without ECG-diagnosed atrial fibrillation. This is the conclusion of the…
View Post 6 min This content is machine translated Cardiac arrhythmias Atrial fibrillation – what do current guidelines say? Atrial fibrillation is the most common sustained cardiac arrhythmia and is associated with significantly increased mortality and morbidity. Therefore, timely diagnostic and therapeutic measures are required. The current ESC guidelines…
